Concepedia

Paul Riska

PR

Statistics

Publications

28

Citations

2K

H-Index

21

Active since

1990

Affiliations

Albert Einstein College of Medicine(Current)

Montefiore Medical Center

National Institute of Allergy and Infectious Diseases

State University of New York

Howard Hughes Medical Institute

Paul Riska is an author at Albert Einstein College of Medicine specializing in infectious diseases, life sciences, and medical microbiology.

Publications per year

1990–2024

28

Publications

28

Disposition and Biotransformation of the Antiretroviral Drug Nevirapine in Humans

Paul Riska, Michael Lamson, Thomas R. MacGregor et al. · Drug Metabolism and Disposition · 1999 · 223 citations

, , +11

The Emperor’s New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE)

Thomas P. Lodise, Susan L. Rosenkranz, Matthew Finnemeyer et al. · Clinical Infectious Diseases · 2019 · 160 citations · Full text

, , +17

Comparison of BD GeneOhm Cdiff Real-Time PCR Assay with a Two-Step Algorithm and a Toxin A/B Enzyme-Linked Immunosorbent Assay for Diagnosis of Toxigenic <i>Clostridium difficile</i> Infection

Elizabeth Jean Kvach, David Ferguson, Paul Riska et al. · Journal of Clinical Microbiology · 2009 · 138 citations · Full text

, , +16

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

Richard T. Davey, Eduardo Fernández‐Cruz, Norman Markowitz et al. · The Lancet Respiratory Medicine · 2019 · 134 citations · Full text

, , +12

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

, , +3

1–5 of 28